Cue Biopharma, Inc.
$37.05
Market Cap
$269.15M
Shares Outstanding
7.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 2, 2018
Round Lot
100
Locale
US
Day Open
$39.35
Day High
$41.00
Day Low
$35.53
Volume
382.0K
VWAP
$38.25
Prev Close
$37.84
Transactions
--
Acc. Volume
--
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Cue Biopharma, Inc. (CUE) closed the 2026-09-18 session at $37.05, down 2.09% versus the previous close (-0.79). The stock opened at $39.35 and traded between $35.53 and $41.00 during that session. Session trading volume was 382K shares. The volume-weighted average price (VWAP) is $38.25.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Cue Biopharma, Inc. has a market capitalization of $269.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CUE is listed on the XNAS exchange. The company employs approximately 29 people. Cue Biopharma, Inc. is headquartered in BOSTON, MA. The recorded listing date is 2018-01-02.
On this page you can find market CUE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.